- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Multiple sclerosis
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 678KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 117KB)
Diroximel fumarate – March 2022
Diroximel fumarate: Capsule 231 mg; Vumerity®
Last updated
1 July 2022